美国 · 平台与数据 · MarketBeat
Viridian Therapeutics, Inc. (NASDAQ:VRDN) Stock Has Average Target Price of $38.92
Shares of Viridian Therapeutics, Inc. (NASDAQ:VRDN - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the twelve analysts that are covering the…
在 MarketBeat 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.marketbeat.com)
